Vitae Pharma Prices 6.875 Mln Shares IPO At $8.00/shr - Quick Facts

(RTTNews) - Vitae Pharmaceuticals Inc., a clinical stage biotechnology company, has priced its initial public offering or IPO of 6.875 million common shares at $8.00 per share. Further, the underwriters were granted a 30-day option to buy up to an additional 1.03 million shares to cover over-allotments at the IPO price. The stock may begin trading on The NASDAQ Global Market on September 24, 2014 under the ticker symbol "VTAE."

Stifel and BMO Capital Markets are acting as joint book-running managers and JMP Securities and Wedbush PacGrow Life Sciences are acting as co-managers for the offering.